Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-12-29
2010-06-29
Gambel, Phillip (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S387300, C530S388100, C424S130100, C424S133100, C424S141100, C424S146100
Reexamination Certificate
active
07745587
ABSTRACT:
Proteins that bind to matrix metalloproteinase 14 and methods of using such proteins are described.
REFERENCES:
patent: 6984619 (2006-01-01), Grdina et al.
patent: 2004/0096899 (2004-05-01), Aoki et al.
patent: 2005/0058725 (2005-03-01), McKearn et al.
patent: 2005/0129615 (2005-06-01), Rozga et al.
patent: 2006/0036076 (2006-02-01), Dransfield et al.
patent: 2006/0275294 (2006-12-01), Omoigui
patent: 2007/0117848 (2007-05-01), Puerta et al.
patent: 2007/0217997 (2007-09-01), Devy et al.
patent: 2008/0076120 (2008-03-01), Donaldson et al.
patent: 2006065533 (2006-06-01), None
Rudikoff et al. PNAS 1982 79:1979.
Padlan et al. PNAS 1989, 86:5938-5942.
Bendig Methods: A Companion to Methods in Enzymology 1995; 8:83-93.
MacCallum et al. J. Mol. Biol. 1996, 262:732-745.
Anilkumar et al., “Palmitoylation at Cys574is essential for MT1-MMP to promote cell migration,”The FASEB Journal, pp. 1-18, Jun. 9, 2005.
Aoki et al., “Cleavage of Apolipoprotein E by Membrane-Type Matrix Metalloproteinase-1 Abrogates Suppression of Cell Proliferation,”J. Biochem. 137, pp. 95-99 (2005).
Bauvois, “Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis?,”Oncogene, 23, pp. 317-329, 2004.
Berno et al., “The 67 kDa Iaminin receptor increases tumor aggressiveness by remodeling laminin-1,”Endocrine-Related Cancer, 12, pp. 393-406 (2005).
Butler et al., “The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A,”The Journal of Biological Chemistry, 273(2), pp. 871-880, Jan. 9, 1998.
Cao et al., “Membrane type I-matrix metalloproteinase promotes human prostate cancer invasion and metastasis,”Thromb Haemost, 93, p. 770-778, 2005.
Cao et al., “Membrane Type Matrix Metalloproteinase 1 Activates Pro-gelatinase A without Furin Cleavage of the N-terminal Domain,” The Journal of Biochemistry, 271(47), pp. 30174-30180, Nov. 22, 1996.
Chang et al., “Activation Systems for Latent Matrix Metalloproteinase-2 Are Upregulated Immediately After Focal Cerebral Ischemia,”Journal of Cerebral Blood Flow&Metabolism, 23, pp. 1408-1419, 2003.
Deryugina et al., “Unexpected Effect of Matrix Metalloproteinase Down-Regulation on Vascular Intravasation and Metastasis of Human Fibrosarcoma Cells Selected In vivo for High Rates of Dissemination,”Cancer Res., 65(23), pp. 10959-10969, Dec. 1, 2005.
Distler et al., “The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles,”PNAS, 102(8), pp. 2892-2897, Feb. 22, 2005.
Dong et al., “Expression of Membrane-Type Matrix Metalloproteinases 4, 5, and 6 in Mouse Corneas Infected withP. aeruginosa,” Investigative Ophthalmology&Visual Science, 42(13), pp. 3223-3227, Dec. 2001.
Dong et al., “Matrix Metalloproteinase Activity and Osteoclasts in Experimental Prostate Cancer Bone Metastasis Tissue,”American Journal of Pathology, 166(4), pp. 1173-1186, Apr. 2005.
El Bedoui et al., “Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression,”Cardiovascular Research, 67, pp. 317-315, 2005.
Folgueras et al., “Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies,”Int. J. Dev. Biol., 48, pp. 411-424 (2004).
Galvez et al., “Membrane Type 1-Matrix Metalloproteinase Is Regulated by Chemokines Monocyte-Chemoattractant Protein-1/CCL2 and Interleukin-8/CXCL8 in Endothelial Cells during Angiogenesis,”The Journal of Biological Chemistry, 280(2), pp. 1292-1298, Jan. 14, 2005.
Giebel et al., “Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier,”Laboratory Investigation, 85, pp. 597-607, 2005.
Gilles et al., “Contribution of MT1-MMP and of human Iaminin-5 γ2 chain degradation to mammary epithelial cell migration,”Journal of Cell Science, 114, pp. 2967-2976, 2001.
Gilles et al., “Implication of Collagen Type I-Induced Membrane-Type 1-Matrix Metalloproteinase Expression and Matrix Metalloproteinase-2 Activation in the Metastatic Progression of Breast Carcinoma,”Laboratory Investigation, 76(5), pp. 651-660, 1997.
Goldbach-Mansky et al., “Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis,”Arthritis Res., 2, pp. 145-153, 2000.
Grossman, “Profiling the evolution of human metastatic bladder cancer,”Urologic Oncology: Seminars and Original Investigations, 23, p. 222, 2005.
Grossman, “Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients,”Urologic Oncology: Seminars and Original Investigations, 23, p. 222-223, 2005.
Guo et al., “Up-Regulation of Angiopoietin-2, Matrix Metalloprotease-2, Membrane Type 1 Metalloprotease, and Laminin 5 γ 2 Correlates with the Invasiveness of Human Glioma,”American Journal of Pathology, 166(3), pp. 877-890, Mar. 2005.
Haas, “Endothelial cell regulation of matrix metalloproteinases,”Can. J. Physiol. Pharmacol., 83, pp. 1-7, 2005.
Handsley et al., “Metalloproteinases and their inhibitors in tumor angiogenesis,”Int. J. Cancer, 115, pp. 849-860, 2005.
Harrison et al., “The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells,”Oncology Reports, 15, pp. 199-206, 2006.
Hayashita-Kinoh et al., “Membrane-Type 5 Matrix Metalloproteinase Is Expressed in Differentiated Neurons and Regulates Axonal Growth,”Cell Growth&Differentiation, 12, pp. 573-580, Nov. 2001.
Hernandez-Barrantes et al., “Regulation of membrane type-matrix metalloproteinases,”Cancer Biology, 12, pp. 131-138, 2002.
Holmbeck et al., “MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover,”Cell, 99, pp. 81-92, Oct. 1, 1999.
Hotary et al., “Matrix Metalloproteinases (MMPs) Regulate Fibrin-invasive Activity via MT1-MMP-dependent and -independent Processes,”J. Exp. Med., 195(3), pp. 295-308, Feb. 4, 2002.
Hwang et al., “A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma,”Biochimica et Biophysica Acta, 1702, pp. 79-87, 2004.
Iida et al., “Melanoma Chondroitin Sulfate Proteoglycan Regulates Matrix Metalloproteinase-dependent Human Melanoma Invasion into Type I Collagen,”The Journal of Biological Chemistry, 276(22), pp. 18786-18794, Jun. 1, 2001.
Itoh et al., “MT1-MMP: A Potent Modifier of Pericellular Microenvironment,”Journal of Cellular Physiology, 206, pp. 1-8, 2006.
Jaworski et al., “Developmental regulation of membrane type-5 matrix metalloproteinase (MT5-MMP) expression in the rat nervous system,”Brain Research, 860, pp. 174-177, 2000.
Kang et al., “Functional characterization of MT3-MMP in transfected MDCK cells: progelatinase A activation and tubulogenesis in 3-D collagen lattice,”The FASEB Journal, 14, pp. 2559-2568, Dec. 2000.
Kevorkian et al., “Expression Profiling of Metalloproteinases and Their Inhibitors in Cartilage,”Arthritis&Rheumatism, 50(1), pp. 131-141, Jan. 2004.
Kinoshita et al., “TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads,”The Journal of Biological Chemistry, 273(26), pp. 16098-16103, Jun. 26, 1998.
Kitagawa et al., “Expression of Messenger RNAs for Membrane-Type 1, 2, and 3 Matrix Metalloproteinases in Human Renal Cell Carcinomas,”The Journal of Urology, 162, pp. 905-909, Sep. 1999.
Kluft, “The Fibrinolytic System and Thrombotic Tendency,”Pathophysiology of Haemostasis and Thrombosis, vol. 33, No. 5-6, pp. 425-429, Sep
Devy Laetitia
Dransfield Daniel T.
Henderikx Maria
Hoet Rene
Ladner Robert C.
Dyax Corp.
Gambel Phillip
Lando & Anastasi LLP
Wen Sharon
LandOfFree
Antibodies that bind MMP-14 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies that bind MMP-14, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies that bind MMP-14 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4216519